Courtney Schreiber, MD, MPH, University of Pennsylvania
Background: There is global consensus that there is benefit to providing Rh immune globulin in the third trimester to prevent immune sensitization and consequent pregnancy complications, however, evidence to guide management of Rh-negative women in the first trimester bleeding is lacking. Our preliminary data indicate that women undergoing abortion in the first trimester are exposed ...Read more >
Eleanor Schwarz, MD, MS, University of California, Davis
Background: This project will build upon existing training resources to develop and pilot a free, online, training resource titled “Medication Abortion in Primary Care.” This training will be designed to meet the needs of general Internists, and other primary care providers who may not be comfortable performing intrauterine procedures. By providing clinicians a continuing medical ...Read more >
Background: Access to safe abortion is declining in the US—especially in the Southeast—and Black, Latinx, and/or lower income women experience disproportionate barriers to abortion care and increased risk for unintended pregnancy, HIV/AIDS, and maternal mortality. Medication abortion has the potential to improve access for marginalized and high-risk women. SisterLove, Inc., a community-based reproductive justice organization ...Read more >
Ila Dayananda, MD, MPH, Planned Parenthood of New York City
Background: Expanding the pool of trained, competent medication abortion providers is necessary to fill gaps in access to safe abortion in the US. The scope of practice for advanced practice clinicians (APCs), including nurse practitioners (NPs), certified nurse midwives (CNMs) and physician assistants (PAs), extends well beyond the skills required to safely manage medication abortion ...Read more >
Mitchell Creinin, MD, University of California, Davis
Background: Medical abortion with mifepristone and misoprostol is highly effective; however, continuing pregnancy can still occur, especially as gestation advances. Even after completing treatment, some women with continuing pregnancies change their mind. Legislators began to focus on women who change their mind after mifepristone administration following a 2012 report of “medical abortion reversal” in which ...Read more >
Alisa Goldberg, MD, MPH, Planned Parenthood League of Massachusetts
Background: Women are seeking abortion at increasingly earlier gestations which increases the likelihood that providers will have difficulty visualizing the pregnancy on ultrasound, the current standard of care in most abortion clinics in the US. Women with no gestational sac visualized on ultrasound have a pregnancy of unknown location (PUL). The most serious risk of ...Read more >
Ushma Upadhyay, PhD, MPH, University of California, San Francisco
Background: New strategies are needed to help people overcome barriers to abortion and achieve greater reproductive autonomy. Demedicalized models for medication abortion care have the potential to greatly expand access to abortion, particularly for those most affected by distance and cost barriers. Methods: The study is a patient-centered, clinically supported, prospective observational study among people ...Read more >
Christopher Ahlbach, BS, University of California, San Francisco
Despite its critical importance in reproductive health, access to safe abortion care in the US and globally continues to be impaired by laws and policies based on religious, political, or other ideologies. Although there is substantial anecdotal evidence about specific beliefs and rationales for opposing abortion provision, identifying specific attitudes, and exploring how those attitudes ...Read more >
Young transgender men (including young people who are transmasculinizing) face disparities in the provision of reproductive health care including contraception, despite their biologic capacity for pregnancy and evidence that this population has a need and desire for these critical services. There is a paucity of evidence describing the contraceptive preferences of transmasculine patients, with almost ...Read more >
Lindsey Yates, MPH, University of North Carolina at Chapel Hill
Black women in the US are more likely to experience unintended and short-interval pregnancies, which are associated with increased risk of adverse birth outcomes for mothers and infants. Long-acting reversible contraception (LARC), including the placement of intrauterine devices (IUDs) or implants, is the most effective contraceptive method for reducing unintended and short-interval pregnancies; however, Black ...Read more >
Close
Menu
PREV
